Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,399 public trials 410 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Recruiting

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

NCT02332668

Conditions
Classical Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +18 more
Locations
  • Call for Information (Investigational Site 0019) Aurora, Colorado, United States
  • Call for Information (Investigational Site 0024) Chicago, Illinois, United States
  • Call for Information (Investigational Site 0026) Boston, Massachusetts, United States
  • Call for Information (Investigational Site 0031) New York, United States
View all 16 locations
View Trial Details
Recruiting

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

NCT06961006

Conditions
Malignant Melanoma, Melanoma, Neoplasms, +11 more
Locations
  • Highlands Oncology Group ( Site 4042) Springdale, Arkansas, United States
  • UCSF Medical Center at Mission Bay ( Site 4044) San Francisco, California, United States
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 4047) Hackensack, New Jersey, United States
  • Inova Schar Cancer Institute ( Site 4046) Fairfax, Virginia, United States
View all 38 locations
View Trial Details
Recruiting

A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies

NCT06839105

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +40 more
Locations
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • The First Affiliated Hospital of Henan University of Science & Technology Luoyang, Henan, China
View all 13 locations
View Trial Details
Recruiting

Adjuvant Tebentafusp in High Risk Ocular Melanoma

NCT06246149

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +11 more
Locations
  • Northwell Health -Center for Advanced Medicine Lake Success, New York, United States
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Centre Antoine Lacassagne Nice, France
  • Institut Curie - Hôpital de Paris Paris, France
View all 15 locations
View Trial Details

Related conditions